Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease

BACKGROUND: Radium-223 chloride ((223)Ra; Alpharadin) is an alpha-emitting radioisotope that targets areas of osteoblastic metastasis and is excreted by the small intestine. When compared with beta-emitters (eg, strontium-89, samarium-153), (223)Ra delivers a high quantity of energy per track length...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Harrison, Michael R, Wong, Terence Z, Armstrong, Andrew J, George, Daniel J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2013
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3544343/
https://ncbi.nlm.nih.gov/pubmed/23326203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S25537
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller